Movement Alert｜Twist Bioscience Falls 5.38% in Regular Trading, Rating Downgrade Triggers Profit-Taking After Early Session Surge

Market Focus07-07

On July 7, Twist Bioscience fell 5.38% in regular trading, trading at $91.11/share, with turnover of $57.73 million. The stock surged to as high as $104.25 earlier in the session before reversing sharply.

On the news front, Evercore ISI downgraded Twist Bioscience from Outperform to In Line on July 6, while simultaneously raising its price target from $66 to $102. Although the target price increase of 54.5% reflects recognition of long-term value, the explicit rating downgrade sent a bearish signal. After the stock surpassed the $102 target price in early trading, the lack of upside support triggered significant profit-taking.

Adding to the selling pressure, the company previously filed a shelf registration statement with the SEC for the potential sale of up to $200 million in common stock under an at-the-market program, creating overhang from potential dilution. The FactSet consensus maintains a buy rating with a mean target price of $87.56, and the company had raised full-year revenue guidance to $435-$440 million following a Q2 sales beat.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1151623384?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-07 22:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151623384","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Twist Bioscience Falls 5.38% in Regular Trading, Rating Downgrade Triggers Profit-Taking After Early Session Surge","media":"Market Focus","content":"<p><p>On July 7, Twist Bioscience fell 5.38% in regular trading, trading at $91.11/share, with turnover of $57.73 million. The stock surged to as high as $104.25 earlier in the session before reversing sharply.</p><p>On the news front, Evercore ISI downgraded Twist Bioscience from Outperform to In Line on July 6, while simultaneously raising its price target from $66 to $102. Although the target price increase of 54.5% reflects recognition of long-term value, the explicit rating downgrade sent a bearish signal. After the stock surpassed the $102 target price in early trading, the lack of upside support triggered significant profit-taking.</p><p>Adding to the selling pressure, the company previously filed a shelf registration statement with the SEC for the potential sale of up to $200 million in common stock under an at-the-market program, creating overhang from potential dilution. The FactSet consensus maintains a buy rating with a mean target price of $87.56, and the company had raised full-year revenue guidance to $435-$440 million following a Q2 sales beat.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Twist Bioscience Falls 5.38% in Regular Trading, Rating Downgrade Triggers Profit-Taking After Early Session Surge</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Twist Bioscience Falls 5.38% in Regular Trading, Rating Downgrade Triggers Profit-Taking After Early Session Surge\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-07 22:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 7, Twist Bioscience fell 5.38% in regular trading, trading at $91.11/share, with turnover of $57.73 million. The stock surged to as high as $104.25 earlier in the session before reversing sharply.</p><p>On the news front, Evercore ISI downgraded Twist Bioscience from Outperform to In Line on July 6, while simultaneously raising its price target from $66 to $102. Although the target price increase of 54.5% reflects recognition of long-term value, the explicit rating downgrade sent a bearish signal. After the stock surpassed the $102 target price in early trading, the lack of upside support triggered significant profit-taking.</p><p>Adding to the selling pressure, the company previously filed a shelf registration statement with the SEC for the potential sale of up to $200 million in common stock under an at-the-market program, creating overhang from potential dilution. The FactSet consensus maintains a buy rating with a mean target price of $87.56, and the company had raised full-year revenue guidance to $435-$440 million following a Q2 sales beat.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWST","symbol_name":"Twist Bioscience Corp","start_time":0,"source_url":"","article_id":"1151623384","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151623384","pubTimestamp":1783435392,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 7, Twist Bioscience fell 5.38% in regular trading, trading at $91.11/share, with turnover of $57.73 million. The stock surged to as high as $104.25 earlier in the session before reversing...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TWST":"Twist Bioscience Corp"},"translate_title":"动向提示|Twist Bioscience常规交易跌5.38%评级下调引发早盘大涨后获利了结","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":1},"content_text":"On July 7, Twist Bioscience fell 5.38% in regular trading, trading at $91.11/share, with turnover of $57.73 million. The stock surged to as high as $104.25 earlier in the session before reversing sharply.On the news front, Evercore ISI downgraded Twist Bioscience from Outperform to In Line on July 6, while simultaneously raising its price target from $66 to $102. Although the target price increase of 54.5% reflects recognition of long-term value, the explicit rating downgrade sent a bearish signal. After the stock surpassed the $102 target price in early trading, the lack of upside support triggered significant profit-taking.Adding to the selling pressure, the company previously filed a shelf registration statement with the SEC for the potential sale of up to $200 million in common stock under an at-the-market program, creating overhang from potential dilution. The FactSet consensus maintains a buy rating with a mean target price of $87.56, and the company had raised full-year revenue guidance to $435-$440 million following a Q2 sales beat.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1151623384","isCrawlerRequest":true}